EGFR and esophageal squamous cell carcinoma: Wang et al. [109] further concluded that all patients with advanced ESCC who responded to icotinib showed EGFR overexpression and that remission rates were significantly higher in ESCC patients with high levels of EGFR expression than in those with low to moderate EGFR expression (17.6% vs. 0%).